The Generic Pharmaceutical Association is about to get a new lead lobbyist: Ralph Neas, whom the New York Times characterizes as "a longtime advocate for liberal causes." Neas told the Times he's "anxious to tell" policy makers about the generics industry's efforts in controlling healthcare costs. Report